世界のインフルエンザワクチン市場動向...市場調査レポートについてご紹介

【英文タイトル】Global Influenza Vaccine Market Outlook 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Analyst View
2. Research Methodology
3. Influenza Vaccine – Introduction
4. Global Influenza Vaccine Market Outlook 2020
4.1 Current Market Overview and Future Outlook
4.2 Major Marketed Vaccines
4.2.1 Fluzone/Vaxigrip
4.2.2 FluMist
4.2.3 Fluarix and Flulaval
4.2.4 Anflu
4.2.5 Fluvax/Afluria
4.2.6 Flucelvax and Fluvirin
5. Key Geographical Market
5.1 US
5.2 Europe
5.3 Emerging Markets
5.3.1 China
5.3.2 India
5.4 Rest of the World
5.4.1 Australia
5.4.2 Japan
6. Global Influenza Vaccine Market: Pipeline Analysis
7. Global Influenza Vaccine Market: Pricing Analysis
8. Competitive Assessment
8.1 Sanofi
8.1.1 Business Description
8.1.2 Financial Overview
8.1.3 Influenza Vaccine Business
8.2 GlaxoSmithKline Plc (GSK)
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Influenza Vaccine Business
8.3 CSL Ltd
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Influenza Vaccine Business
8.4 AstraZeneca Plc
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Influenza Vaccine Business
8.5 Sinovac Biotech
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Influenza Vaccine Business
8.6 Serum Institute of India
8.6.1 Business Overview
8.6.2 Influenza Vaccine Business

List of Figures:

Figure 4-1: Global – Production Capacity and Production of Influenza Vaccine (Million Doses), 2009 & 2011
Figure 4-2: Global – Influenza Vaccine Sales (Million Doses), 2014 & 2020
Figure 4-3: Global – Influenza Vaccine Market (Billion US$), 2014-2020
Figure 4-4: Global – Influenza Vaccine Market by Players (%), 2014
Figure 4-5: Global – Fluzone/Vaxigrip Sales (Million US$), 2010-2014
Figure 4-6: Global – FluMist Sales (Million US$), 2010-2014
Figure 4-7: Global – Fluarix and FluLaval Sales (Million US$), 2010-2014
Figure 4-8: Global – Anflu Sales (Million Doses), 2010-2013
Figure 4-9: Global – Anflu Sales (Million Doses), 2010-2013
Figure 4-10: Global – Afluria/Fluvax Sales (Million US$), 2012-2014
Figure 4-11: Global – Flucevax and Fluvirin Sales (Million US$), 2012-2014
Figure 5-1: Global – Influenza Vaccine Market by Region (%), 2014
Figure 5-2: US – Influenza Vaccine Sales (Million Doses), 2009-10 to 2014-15
Figure 5-3: US – Influenza Vaccine Market by Players (%), 2014
Figure 5-4: US – Influenza Vaccine Market (Billion US$), 2014-2020
Figure 5-5: Europe – Influenza Vaccine Market by Players (%), 2014
Figure 5-6: Europe – Influenza Vaccine Market (Million US$), 2014-2020
Figure 5-7: Europe – Seasonal Influenza Vaccination Coverage in Older Age Group by Country (%), 2011-12 & 2012-13
Figure 5-8: Emerging Markets – Influenza Vaccine Market by Players (%), 2014
Figure 5-9: Emerging Markets – Influenza Vaccine Market (Million US$), 2014-2020
Figure 5-10: Rest of the World – Influenza Vaccine Market (Million US$), 2014-2020
Figure 8-1: Sanofi – Breakup of Total Revenues by Business Segment (%), 2014
Figure 8-2: Sanofi Pasteur – Breakup of Vaccine Segment by Type (%), 2014
Figure 8-3: Sanofi Pasteur – Breakup of Total Influenza Vaccine Revenues by Geography (%), 2014
Figure 8-4: GlaxoSmithKline Plc – Breakup of Total Revenues by Business Segment (%), 2014
Figure 8-5: GlaxoSmithKline Plc – Breakup of Vaccine Segment by Type (%), 2014
Figure 8-6: GlaxoSmithKline Plc – Breakup of Total Influenza Vaccine Revenue by Geography (%), 2014
Figure 8-7: CSL Ltd – Breakup of Total Revenues by Business Segment (%), 2014
Figure 8-8: CSL Ltd – Breakup of bioCSL Revenues by Product Type (%), 2014
Figure 8-9: AstraZeneca Plc – Breakup of Total Revenues by Business Segment (%), 2014
Figure 8-10: AstraZeneca Plc – Breakup of Infection Segment by Type (%), 2014
Figure 8-11: AstraZeneca Plc – Breakup of Total Influenza Vaccine Revenues by Geography (%), 2014
Figure 8-12: Sinovac Biotech – Breakup of Vaccine by Type (%), 2013

List of Tables:

Table 5-1: US – Major Influenza Vaccines & Manufacturers (2014-15)
Table 5-2: Percentage of People in the US Who Received Influenza Vaccine (2013-14)
Table 5-3: Number of Pediatric Deaths in US Flu Season (2005-06 to 2014-15)
Table 5-4: US – Seasonal Influenza Vaccination Coverage by Group (%), 2011-12 to 2013-14
Table 5-5: Europe – Major Influenza Vaccines & Manufacturers (2014-15)
Table 5-6: China – Vaccine Classification
Table 5-7: Australia – Major Influenza Vaccines & Manufacturer (2014-15)
Table 6-1: Influenza Vaccine – Pipeline Analysis, 2014
Table 7-1: Major Influenza Vaccines Cost/Dose (US$) for 2015-16 Season
Table 8-1: Sanofi – Key Financials (Million US$), 2012-2014
Table 8-2: Influenza Vaccines Offered by Sanofi Pasteur (2014)
Table 8-3: GlaxoSmithKline Plc – Key Financials (Million US$), 2012-2014
Table 8-4: Influenza Vaccines Offered by GlaxoSmithKline Plc (2014)
Table 8-5: CSL Ltd. – Key Financials (Million US$), 2012-2014
Table 8-6: CSL Influenza Vaccine Portfolio before Merger
Table 8-7: CSL Influenza Vaccine Portfolio after Merger
Table 8-8: AstraZeneca Plc – Key Financials (Million US$), 2012-2014
Table 8-9: Influenza Vaccines Offered by AstraZeneca Plc (2014)
Table 8-10: Sinovac Biotech – Key Financials (Million US$), 2011-2013
Table 8-11: Influenza Vaccines Offered by Sinovac Biotech (2014)


【レポート販売概要】

■ タイトル:世界のインフルエンザワクチン市場動向
■ 英文:Global Influenza Vaccine Market Outlook 2020
■ 発行日:2015年4月
■ 調査会社:RNCOS
■ 商品コード:RNCOS5042103
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。